{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:10:45Z","timestamp":1784333445099,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejim.2025.04.024","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T15:45:37Z","timestamp":1749224737000},"page":"106317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Long-term secondary prevention with colchicine in patients with CAD: an updated systematic review and meta-analysis"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8506-2005","authenticated-orcid":false,"given":"Patrizia","family":"Boracchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0239-7297","authenticated-orcid":false,"given":"Giuseppe","family":"Marano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-9370","authenticated-orcid":false,"given":"Ester","family":"Luconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2919-709X","authenticated-orcid":false,"given":"Claudio","family":"Cimminiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2025.04.024_bib0001","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials","volume":"42","author":"Fiolet","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.04.024_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2024.01.004","article-title":"The impact of colchicine on patients with acute and chronic coronary artery disease","volume":"125","author":"Madanchi","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2025.04.024_bib0003","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes. Developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.04.024_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.04.024_bib0005","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.04.024_bib0006","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.04.024_bib0007","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in Patients with Chronic Coronary Disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.04.024_bib0008","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation."},{"key":"10.1016\/j.ejim.2025.04.024_bib0009","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s44161-024-00600-2","article-title":"Implications and limitations of the CLEAR-SYNERGY trial for the use of low-dose colchicine in cardiovascular disease","volume":"4","author":"Misra","year":"2025","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.ejim.2025.04.024_bib0010","first-page":"843","article-title":"Efficacy and safety of colchicine and spironolactone after myocardial infarction: the CLEAR-SYNERGY trial in perspective","volume":"13","author":"Tardif","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.ejim.2025.04.024_bib0011","article-title":"Colchicine for prevention of major adverse cardiovascular events","author":"Ballacci","year":"2024","journal-title":"System Rev Meta-Analy Random Clinic Trials"},{"key":"10.1016\/j.ejim.2025.04.024_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-025-01124-3","article-title":"Colchicine in acute coronary syndromes: the present and the possible future","author":"Imazio","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejim.2025.04.024_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.ejim.2025.04.024_bib0014","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.ejim.2025.04.024_bib0015","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ejim.2025.04.024_bib0016","article-title":"Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024)","author":"Higgins","year":"2024","journal-title":"Cochrane"},{"key":"10.1016\/j.ejim.2025.04.024_bib0017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12874-022-01541-9","article-title":"Implications of analysing time-to-event outcomes as binary in meta-analysis: empirical evidence from the cochrane database of systematic reviews","volume":"22","author":"Salika","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejim.2025.04.024_bib0018","series-title":"R: A language and environment for statistical computing","year":"2023"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.024_bib0019","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.024_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Soft"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.024_bib0021","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.04.024_bib0022","first-page":"ehae897","article-title":"Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction","author":"Liuzzo","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.04.024_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-079061","article-title":"CHANCE-3 investigators. Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial","volume":"385","author":"Li","year":"2024","journal-title":"BMJ"},{"issue":"10448","key":"10.1016\/j.ejim.2025.04.024_bib0024","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(24)00968-1","article-title":"Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial","volume":"404","author":"Kelly","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2025.04.024_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133045","article-title":"Colchicine for secondary prevention in patients with acute coronary syndrome: a systematic review and meta-analysis","volume":"425","author":"Shaikh","year":"2025","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.ejim.2025.04.024_bib0026","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jamainternmed.2021.5726","article-title":"Assessment of nonfatal myocardial infarction as a surrogate for all-cause and cardiovascular mortality in treatment or prevention of coronary artery disease: a meta-analysis of randomized clinical trials","volume":"181","author":"O'Fee","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.024_bib0027","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/ehjcvp\/pvaa137","article-title":"Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underling possible safety concerns","volume":"7","author":"Galli","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.ejim.2025.04.024_bib0028","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejim.2024.05.016","article-title":"Low-dose colchicine for chronic stable atherosclerosis: under-appreciated and under-prescribed","volume":"125","author":"Ridker","year":"2024","journal-title":"Eur J Intern Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525001645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525001645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:45:20Z","timestamp":1780901120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525001645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"alternative-id":["S0953620525001645"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.04.024","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term secondary prevention with colchicine in patients with CAD: an updated systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106317"}}